Updated European Consensus Statement on diagnosis and treatment of adult ADHD
Autor: | K. Foeken, Florina Rad, Asko Niemelä, S. Young, Julio Bobes, Stefano Pallanti, Luana Salerno, S. Markovska Simoska, Judit Balazs, V. Richarte, E. Sobanski, Bengi Semerci, Ylva Ginsberg, T. Lehtonen, Josep Antoni Ramos-Quiroga, P. Brudkiewicz, N. Motavalli Mukaddes, T. Saito, D. Baeyens, Jane McCarthy, István Bitter, C. Nunes Filipe, Sami Leppämäki, Artemios Pehlivanidis, Pekka Tani, P. Asherson, Martin D. Ohlmeier, A. Kjems Philipsen, Johanna Krause, Richard Delorme, B. Styr, Z. Félegyházy, Michael Fitzgerald, J.J.S. Kooij, Michael B. Lensing, Ilinca Mihailescu, M.P. García-Portilla, V. Pironti, Susanne Bejerot, Blanca Bolea-Alamanac, Pieter-Jan Carpentier, D. Edvinsson, U. Müller-Sedgwick, Fiona McNicholas, James Kustow, Alexandra Philipsen, Johannes Thome, Michael Gill, Hervé Caci, Iris Manor, S. Stes, John Fayyad, Denise Bijlenga, R. Jaeschke, Marios Adamou, Geert Dom, Pavel Mohr, Peik Gustafsson, Iuliana Dobrescu, Miguel Casas, P. De Rossi, P. Oswald, Dora Wynchank, Siegfried Kasper, Tatja Hirvikoski |
---|---|
Přispěvatelé: | Department of Psychiatry, Clinicum, University of Helsinki, HUS Psychiatry, HKÜ, Sağlık Bilimleri Fakültesi, Psikoloji Bölümü, Psychiatry, APH - Mental Health, VU University medical center, APH - Health Behaviors & Chronic Diseases |
Jazyk: | angličtina |
Rok vydání: | 2019 |
Předmět: |
Male
MENTAL-HEALTH-SERVICES medicine.medical_treatment Adult ADHD Updated European Consensus Statement Diagnosis Treatment European Network Adult ADHD EPA SERIOUS CARDIOVASCULAR EVENTS MEDICATION-TREATED ADULTS GUANFACINE EXTENDED-RELEASE Health Services Accessibility 3124 Neurology and psychiatry law.invention 0302 clinical medicine Randomized controlled trial law Prevalence Psychology COGNITIVE-BEHAVIORAL THERAPY Borderline personality disorder Psychiatry BORDERLINE PERSONALITY-DISORDER RANDOMIZED CONTROLLED-TRIAL 3. Good health ATTENTION-DEFICIT/HYPERACTIVITY-DISORDER Europe Substance abuse Cognitive behavioral therapy Psychiatry and Mental health Practice Guidelines as Topic Female Adult medicine.medical_specialty Consensus MEDLINE behavioral disciplines and activities Psykiatri 03 medical and health sciences mental disorders medicine Humans Attention deficit hyperactivity disorder DEFICIT-HYPERACTIVITY-DISORDER business.industry medicine.disease Mental health 030227 psychiatry Psychotherapy Attention Deficit Disorder with Hyperactivity Diagnostic assessment Central Nervous System Stimulants SUBSTANCE USE DISORDER Human medicine business 030217 neurology & neurosurgery |
Zdroj: | Dipòsit Digital de Documents de la UAB Universitat Autònoma de Barcelona WOS:000458502900003 European psychiatry Kooij, J J S, Bijlenga, D, Salerno, L, Jaeschke, R, Bitter, I, Balázs, J, Thome, J, Dom, G, Kasper, S, Nunes Filipe, C, Stes, S, Mohr, P, Leppämäki, S, Casas Brugué, M, Bobes, J, Mccarthy, J M, Richarte, V, Kjems Philipsen, A, Pehlivanidis, A, Niemela, A, Styr, B, Semerci, B, Bolea-Alamanac, B, Edvinsson, D, Baeyens, D, Wynchank, D, Sobanski, E, Philipsen, A, McNicholas, F, Caci, H, Mihailescu, I, Manor, I, Dobrescu, I, Krause, J, Fayyad, J, Ramos-Quiroga, J A, Foeken, K, Rad, F, Adamou, M, Ohlmeier, M, Fitzgerald, M, Gill, M, Lensing, M, Motavalli Mukaddes, N, Brudkiewicz, P, Gustafsson, P, Tani, P, Oswald, P, Carpentier, P J, de Rossi, P, Delorme, R, Markovska Simoska, S, Pallanti, S, Young, S, Bejerot, S, Lehtonen, T, Kustow, J, Müller-Sedgwick, U, Hirvikoski, T, Pironti, V, Ginsberg, Y, Félegeházy, Z, Garcia-Portilla, M P & Asherson, P 2019, ' Updated European Consensus Statement on diagnosis and treatment of adult ADHD ', European Psychiatry, vol. 56, pp. 14-34 . https://doi.org/10.1016/j.eurpsy.2018.11.001 European Psychiatry, 56, 14-34. Elsevier Masson RUO. Repositorio Institucional de la Universidad de Oviedo instname |
ISSN: | 0924-9338 |
DOI: | 10.1016/j.eurpsy.2018.11.001 |
Popis: | Background Attention-deficit/hyperactivity disorder (ADHD) is among the most common psychiatric disorders of childhood that often persists into adulthood and old age. Yet ADHD is currently underdiagnosed and undertreated in many European countries, leading to chronicity of symptoms and impairment, due to lack of, or ineffective treatment, and higher costs of illness.Methods The European Network Adult ADHD and the Section for Neurodevelopmental Disorders Across the Lifespan (NDAL) of the European Psychiatric Association (EPA), aim to increase awareness and knowledge of adult ADHD in and outside Europe. This Updated European Consensus Statement aims to support clinicians with research evidence and clinical experience from 63 experts of European and other countries in which ADHD in adults is recognized and treated.Results Besides reviewing the latest research on prevalence, persistence, genetics and neurobiology of ADHD, three major questions are addressed: (1) What is the clinical picture of ADHD in adults? (2) How should ADHD be properly diagnosed in adults? (3) How should adult ADHDbe effectively treated?Conclusions ADHD often presents as a lifelong impairing condition. The stigma surrounding ADHD, mainly due to lack of knowledge, increases the suffering of patients. Education on the lifespan perspective, diagnostic assessment, and treatment of ADHD must increase for students of general and mental health, and for psychiatry professionals. Instruments for screening and diagnosis of ADHD in adults are available, as are effective evidence-based treatments for ADHD and its negative outcomes. More research is needed on gender differences, and in older adults with ADHD. |
Databáze: | OpenAIRE |
Externí odkaz: |